id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-291421-mrm9paiq	Meijer, Eelco F. J.	Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report	2020-06-06		.txt	text/plain	3106	173	44	COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity affecting patients with severe pulmonary abnormalities treated in intensive care units. COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity affecting patients in intensive care unit (ICUs) with severe pulmonary abnormalities. We present the first case of azole-resistant Aspergillus fumigatus in a SARS-CoV-2-positive immunocompetent patient admitted to the ICU. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: Comparison with the diagnostic performance of galactomannan and of (1→3)-β-d-glucan chromogenic assay in serum samples Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: A combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis Performance of galactomannan, 1,3-β-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis	./cache/cord-291421-mrm9paiq.txt	./txt/cord-291421-mrm9paiq.txt